Biochemical and Biophysical Research Communications, Vol.296, No.5, 1083-1090, 2002
Identification of nuclear type II[H-3]estradiol binding sites as histone H4
[H-3]Luteolin binds covalently to uterine nuclear type II sites [B. Markaverich, K. Shoulars, M.A. Alejandro, T. Brown, Steroids 66 (2001) 707] and was used to identify this protein(s). SDS-PAGE analyses of [H-3]luteolin-labeled type II site preparations revealed specific binding to 11- and 35-kDa proteins. The 11-kDa protein was identified as histone H4 by amino acid sequencing. Western blotting confirmed that the 11- and 35-kDa-proteins were acetylated forms of histone H4. Anti-histone H4 antibodies (but not H2A, H2B, or H3 antibodies) quantitatively immunoadsorbed type II binding sites from nuclear extracts. Binding analyses by [H-3]estradiol exchange, using luteolin as a competitor, detected specific type II binding activity to histone H4 (but not histones H2A, H2B, or H3) generated in a rabbit reticulocyte lysate translation system and confirmed that histone H4 is the type II site. (C) 2002 Elsevier Science (USA). All rights reserved.
Keywords:type II[H-3]estradiol binding site;histone H4;luteolin;bioflavonoid;methyl p-hydroxyphenyllactate (MeHPLA);rat uterus